Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
about
Evolution of MHC-based technologies used for detection of antigen-responsive T cellsMuPeXI: prediction of neo-epitopes from tumor sequencing data.Systematic evaluation of immune regulation and modulationT cell receptor repertoire usage in cancer as a surrogate marker for immune responses.Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.Combining radiotherapy with immunotherapy: the past, the present and the future.Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans.Non-Invasive Monitoring of CNS MHC-I Molecules in Ischemic Stroke Mice.The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy.Identification and correction of spatial bias are essential for obtaining quality data in high-throughput screening technologies.Leveraging blood and tissue CD4+ T cell heterogeneity at the single cell level to identify mechanisms of disease in rheumatoid arthritis.'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Host genotype and time dependent antigen presentation of viral peptides: predictions from theory.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes.Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?Informatics for cancer immunotherapy.Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Preclinical and clinical development of neoantigen vaccines.Expanding the Toolkit for the Study of Allospecific B and T Cell Responses.The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells.Neoantigen Vaccine Delivery for Personalized Anticancer ImmunotherapyDetermining T-cell specificity to understand and treat diseaseIsolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding
P2860
Q33607055-16CF320D-C2D6-4042-A6E9-0BD69CD389C3Q36352986-FB74BEA1-F00A-427C-B928-BE49B04CB316Q37713498-C4F4567D-68E3-4998-A055-417234DFA960Q38376433-9E994DDF-A279-47CB-B6D4-D32F6061FB0DQ38612613-3B3CECDB-45CD-49EA-A1E8-941ECBB42D5AQ38679418-6F623726-D2D9-4089-A120-7A46E174C8CEQ39366464-D1599A07-EFEB-4EAD-AF0D-4AFB7DF2089DQ41455482-1AF8627C-945D-4C71-94D8-2D737C47C99FQ41673084-60FCE9F6-CE9F-485A-8160-B4F1BD23642FQ41897369-636CB5AE-9D56-40E3-8FFD-E17BF6149EDEQ42777634-055030EC-82F3-4688-8D8D-4C8186B262B9Q45718710-09047339-69EA-41A5-A151-3E761E109B0DQ46721978-0A3E8C69-340E-49FC-A5CA-B4DA66C6202CQ46832079-EAC520EB-208D-40C3-B026-B1FCBB8743D8Q47133741-CB8FB4AF-3784-4404-92FD-877E04959BDCQ47162995-26C2EA61-32DC-495E-9E82-C834127B851FQ47220965-E457AD12-975E-4ACD-8377-22766449D286Q47221163-F91EA79F-F9C7-4B0E-8EAB-903AC2685D13Q47290509-D5876316-FDA0-4E57-91FB-EF1FD7551476Q47571383-17097700-095E-498E-91C8-C30EB50379AAQ49307766-502A9677-9903-4E2F-A976-279362EB2C8DQ49483662-43A59A06-BA4A-4E6E-AC56-FE7257493115Q49668436-2A761391-0B76-46FB-B49B-C737A8144FFFQ50068734-E13CEAF8-B8C9-470C-B560-34D43B2DE9E2Q52720460-858C504B-5CE1-4875-B720-0E4B791F59AEQ54233814-A0FA28FD-9BA2-411B-8452-475EFC38624CQ57177418-0A13941D-C9ED-45D4-9814-791DDED7D1D9Q57201489-26EFDAF4-63F5-4F4F-A256-E877B1D8813BQ57310383-DFF31EFA-601B-460B-88EC-C99B606464A0
P2860
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Large-scale detection of antig ...... ers labeled with DNA barcodes.
@en
type
label
Large-scale detection of antig ...... ers labeled with DNA barcodes.
@en
prefLabel
Large-scale detection of antig ...... ers labeled with DNA barcodes.
@en
P2093
P2860
P50
P356
P1433
P1476
Large-scale detection of antig ...... mers labeled with DNA barcodes
@en
P2093
Amalie Kai Bentzen
Andrew J S Furness
Per Thor Straten
Rachel Rosenthal
Rikke Lyngaa
P2860
P2888
P304
P356
10.1038/NBT.3662
P50
P577
2016-08-29T00:00:00Z